Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dingkundan and Diane-35 in Polycystic Ovary Syndrome
NCT03264638Phase 2Unknown
- Start
- Oct 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dingkundan in polycystic ovary syndrome (PCOS). Primary endpoint: Clinical Symptoms at 5 minutes. Status: unknown.
02
Drugs
dingkundan
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03264638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03264638.